tiprankstipranks
Bio-Path Holdings Faces Nasdaq Compliance and Strategic Changes
Company Announcements

Bio-Path Holdings Faces Nasdaq Compliance and Strategic Changes

Story Highlights

Pick the best stocks and maximize your portfolio:

An announcement from Bio-Path Holdings ( (BPTH) ) is now available.

Bio-Path Holdings, Inc. has been notified by Nasdaq that its common stock has not met the minimum required bid price for continued listing, giving the company an initial 180-day period to comply. At its 2024 annual meeting, the company received stockholder approval for several measures, including increasing shares under its stock incentive plan and a potential reverse stock split, to address compliance and strategic objectives.

More about Bio-Path Holdings

YTD Price Performance: -92.44%

Average Trading Volume: 1,202,473

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: $3.02M

Learn more about BPTH stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskBio-Path Holdings Shifts Focus to Metabolic Program
TheFlyBio-Path outlines rationale for development of BP1001-A
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App